Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Change in Inventory: 2023-2025

Historic Change in Inventory for Gyre Therapeutics (GYRE) over the last 3 years, with Sep 2025 value amounting to -$72,000.

  • Gyre Therapeutics' Change in Inventory fell 111.32% to -$72,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year increase of 38.32%. This contributed to the annual value of $2.1 million for FY2024, which is 222.44% up from last year.
  • As of Q3 2025, Gyre Therapeutics' Change in Inventory stood at -$72,000, which was down 107.55% from $954,000 recorded in Q2 2025.
  • Gyre Therapeutics' Change in Inventory's 5-year high stood at $1.5 million during Q1 2025, with a 5-year trough of -$921,000 in Q3 2023.
  • In the last 3 years, Gyre Therapeutics' Change in Inventory had a median value of $118,000 in 2024 and averaged $255,909.
  • Per our database at Business Quant, Gyre Therapeutics' Change in Inventory soared by 714.53% in 2024 and then slumped by 111.32% in 2025.
  • Gyre Therapeutics' Change in Inventory (Quarterly) stood at -$184,000 in 2023, then surged by 164.13% to $118,000 in 2024, then crashed by 111.32% to -$72,000 in 2025.
  • Its last three reported values are -$72,000 in Q3 2025, $954,000 for Q2 2025, and $1.5 million during Q1 2025.